Patents by Inventor Geoffrey Purdum

Geoffrey Purdum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug delivery system and method for the treatment of neuro-degenerative disease
    Patent number: 10485766
    Abstract: Embodiments of the present invention are directed to the oral administration of Bryostatins for the treatment of neuro-degenerative disease.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: November 26, 2019
    Assignees: Aphios Corporation, Board of Supervisors of the Louisiana State University and Agricultural and Mechanical College
    Inventors: Trevor Percival Castor, Jonathan Steven Alexander, Geoffrey Purdum, J. David Rios, Lisa M. Schrott, Theodore A. Tyler, Maria I. Vizcaino
  • DRUG DELIVERY SYSTEM AND METHOD FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASE
    Publication number: 20150246000
    Abstract: Embodiments of the present invention are directed to the oral administration of Bryostatins for the treatment of neuro-degenerative disease.
    Type: Application
    Filed: May 18, 2015
    Publication date: September 3, 2015
    Inventors: Trevor Percival Castor, Jonathan Steven Alexander, Geoffrey Purdum, J. David Rios, Lisa M. Schrott, Theodore A. Tyler, Maria I. Vizcaino
  • Drug delivery system and method for the treatment of neuro-degenerative disease
    Patent number: 9034347
    Abstract: Embodiments of the present invention are directed to the oral administration of Bryostatins for the treatment of neuro-degenerative disease.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: May 19, 2015
    Assignees: Arphios Corporation, For the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College acting on behalf of Louisiana State University Health Sciences Center at Shreveport
    Inventors: Trevor Percival Castor, Jonathan Steven Alexander, Geoffrey Purdum, J. David Rios, Lisa M. Schrott, Theodore A. Tyler, Maria I. Vizcaino
  • Nanoencapsulated delta-9-tetrahydrocannabinol
    Patent number: 8629177
    Abstract: Embodiments of the present invention are directed to articles of manufacture and methods of making such articles having utility for the delivery of cannabinoids as a therapeutic. One embodiment of the present invention directed to the article of manufacture comprises a lyophilized particle or sphere having a diameter of about 100 to 500 nanometers having a shell and comprising a biodegradable polymer containing a cannabinoid. A featured cannabinoid is delta-9-tetrahydrocannabinol (delta-9-THC).
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: January 14, 2014
    Assignee: Aphios Corporation
    Inventors: Trevor Percival Castor, Geoffrey Purdum
  • NANOENCAPSULATED DELTA-9-TETRAHYDROCANNABINOL
    Publication number: 20120052119
    Abstract: Embodiments of the present invention are directed to articles of manufacture and methods of making such articles having utility for the delivery of cannabinoids as a therapeutic. One embodiment of the present invention directed to the article of manufacture comprises a lyophilized particle or sphere having a diameter of about 100 to 500 nanometers having a shell and comprising a biodegradeable polymer containing a cannabinoid. A featured cannabinoid is delta-9-tetrahydrocannabinol (delta-9-THC).
    Type: Application
    Filed: August 23, 2011
    Publication date: March 1, 2012
    Inventors: Trevor Percival CASTOR, Geoffrey Purdum